Warning! GuruFocus detected
1 Severe warning sign
with MNMD.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Mind Medicine Inc
NAICS : 325199
SIC : 3741
ISIN : CA60255C8850
Share Class Description:
MNMD: Ordinary SharesCompare
Compare
Traded in other countries / regions
MNMD.USAMMED.CanadaMMQ.Germany Index Membership
Russell 2000Russell 3000Russell 2000 IPO Date
2020-03-03Description
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.53 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 23.3 | |||||
| 3-Year EPS without NRI Growth Rate | 26.6 | |||||
| 3-Year FCF Growth Rate | 12.5 | |||||
| 3-Year Book Growth Rate | -15.9 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.04 | |||||
| 9-Day RSI | 41.24 | |||||
| 14-Day RSI | 43.18 | |||||
| 3-1 Month Momentum % | -2.05 | |||||
| 6-1 Month Momentum % | 14.53 | |||||
| 12-1 Month Momentum % | -29.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.25 | |||||
| Quick Ratio | 7.25 | |||||
| Cash Ratio | 7.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -38.8 | |||||
| Shareholder Yield % | -54.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -55.46 | |||||
| ROA % | -42.12 | |||||
| ROIC % | -195.72 | |||||
| 3-Year ROIIC % | -51.3 | |||||
| ROCE % | -49.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.97 | |||||
| Price-to-Tangible-Book | 2.15 | |||||
| EV-to-EBIT | -2.17 | |||||
| EV-to-EBITDA | -2.18 | |||||
| EV-to-Forward-EBITDA | -1.94 | |||||
| EV-to-FCF | -3.08 | |||||
| Price-to-Net-Current-Asset-Value | 2.17 | |||||
| Price-to-Net-Cash | 2.24 | |||||
| Earnings Yield (Greenblatt) % | -46.08 | |||||
| FCF Yield % | -16.53 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:MNMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mind Medicine Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.08 | ||
| Beta | 2.82 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.16 | ||
| Volatility % | 91.03 | ||
| 14-Day RSI | 43.18 | ||
| 14-Day ATR ($) | 0.487469 | ||
| 20-Day SMA ($) | 6.51425 | ||
| 12-1 Month Momentum % | -29.47 | ||
| 52-Week Range ($) | 5.0329 - 12.22 | ||
| Shares Outstanding (Mil) | 75.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mind Medicine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mind Medicine Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mind Medicine Inc Frequently Asked Questions
What is Mind Medicine Inc(MNMD)'s stock price today?
The current price of MNMD is $6.35. The 52 week high of MNMD is $12.22 and 52 week low is $5.03.
When is next earnings date of Mind Medicine Inc(MNMD)?
The next earnings date of Mind Medicine Inc(MNMD) is 2025-05-08 Est..
Does Mind Medicine Inc(MNMD) pay dividends? If so, how much?
Mind Medicine Inc(MNMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers